Glaxosmithkline Pharmaceuticals informs about details of loss of certificate

15 Dec 2023 Evaluate
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company KFin Technologies has received request for issue of duplicate Share Certificates from Shareholders. Details enclosed. The Company shall issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2264.55 -5.25 (-0.23%)
21-Jan-2026 14:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1614.45
Dr. Reddys Lab 1157.45
Cipla 1371.15
Zydus Lifesciences 876.40
Lupin 2143.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×